Surmodics | Aktywa





Aktywa Zmiana Data
Abbott USD 84.18B 182M 2025-09
Align Technology USD 6.23B 141K 2025-12
Anika Therapeutics USD 189.44M 1.76M 2025-09
Arrowhead Research USD 1.6B 218.89M 2025-12
Baxter International USD 21.07B 21M 2025-09
Boston Scientific USD 42.71B 1.15B 2025-09
EDAP TMS EUR 61.46M 6.88M 2025-09
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Haemonetics USD 2.49B 48.73M 2025-12
Heron Therapeutics USD 248.95M 16.86M 2025-09
J&J USD 192.82B 573M 2025-09
Merit Medical Systems USD 2.63B 44.95M 2025-09
Mesa Laboratories USD 434.85M 4.5M 2025-12
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Option Care Health USD 3.48B 97.02M 2025-09
Stryker USD 47.84B 787M 2025-12
Surmodics USD 178.56M 1.15M 2024-09
Trinity Biotech USD 103.71M 4.08M 2025-09


Surmodics Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.